logo
  • Provider Resources
    • Education
    • HCP Consensus Statements from CJON
    • HCP Toolkits
    • ctDNA Testing for Response Monitoring
    • BRAF Testing
    • Care Step Pathways
    • Side Effect Search
    • Videos
  • Decision Support Tools
    • Options for Stage II Melanoma
    • Options for Stage III Melanoma
    • Options for Stage IV Melanoma
  • Patient Resources
    • Patient Action Plans
    • Non-Invasive Evaluation Tools For Suspicious Spots
    • BRAF Q&A
    • ctDNA Testing Handout
    • Videos
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Provider Resources
    • Education
    • HCP Consensus Statements from CJON
    • HCP Toolkits
    • ctDNA Testing for Response Monitoring
    • BRAF Testing
    • Care Step Pathways
    • Side Effect Search
    • Videos
  • Decision Support Tools
    • Options for Stage II Melanoma
    • Options for Stage III Melanoma
    • Options for Stage IV Melanoma
  • Patient Resources
    • Patient Action Plans
    • Non-Invasive Evaluation Tools For Suspicious Spots
    • BRAF Q&A
    • ctDNA Testing Handout
    • Videos
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK

The Melanoma Hub – Home › Forums › Intralesional immunotherapy

  • This category has 6 topics, 20 replies, and was last updated April 29, 2018 at 2:54 pm by Kathleen Madden.
    • Forum
    • Topics
    • Posts
    • Last Post
    • Expectations for therapy
    • 0
    • 0
    • No Topics

    • Dosing and administration
    • 2
    • 8
    • Reply To: Premedication

      April 29, 2018 at 2:54 pm

      Kathleen Madden

    • Infectious Precautions
    • 2
    • 9
    • Reply To: TVEC infection control practices

      February 11, 2018 at 12:00 am

      Krista Rubin

    • Side-effect management
    • 1
    • 8
    • Reply To: Ocular herpes

      January 5, 2018 at 2:54 am

      Virginia Seery

    • Reimbursement
    • 1
    • 1
    • December 8, 2017 at 4:58 pm

    • Other
    • 0
    • 0
    • No Topics

  •  

Login

Log In
Register Lost Password

Latest Activity

  • Immunotherapy in Hepatitis B carriers
    topic by Suzanne McGettigan
    February 25
    in Other
  • Esophagitis
    reply by Suzanne McGettigan
    February 18
    in Side-effect management
  • mucositis & mouth sores from Nivo
    reply by Kathleen Madden
    January 27
    in Side-effect management
  • Immunotherapy and Solid organ transplant
    reply by Krista Rubin
    January 23
    in Other
  • Nivolumab dilution
    reply by Kathleen Madden
    November 18
    in Dosing and administration
© 2024 The Melanoma Hub, Terranova Medica, LLC, and Integrita Foundation, LLC. All rights reserved.
  • About
  • Terms
  • Privacy
  • Contact